Commentary

Podcast

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Expert discussed benefits of precision oncology treatments that utilize thousands of biomarkers to design personalized treatment plans.

About the Expert

John Oertle, NMD, is the Chief Medical Officer of Envita Medical Center — an advanced cancer and Lyme disease treatment center specializing in holistic, personalized care to improve patient outcome.

John Oertle, NMD, Chief Medical Officer of Envita Medical Center, discussed the rising rates of lung cancer in young adults, including non-smokers. Oertle explained how Envita's precision oncology model utilizes thousands of biomarkers to develop personalized treatment plans, leading to significantly improved outcomes compared to standard care. He also emphasized important risk factors like environmental exposures and infections, as well as the importance of early cancer screening and adopting healthy lifestyle habits to reduce cancer risks.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com